Next Article in Journal
Impaired Release of Neutrophil Extracellular Traps and Anemia-Associated T Cell Deficiency in Hereditary Hemorrhagic Telangiectasia
Previous Article in Journal
Metabolic Alterations Associated with Early-Stage Hepatocellular Carcinoma and Their Correlation with Aging and Enzymatic Activity in Patients with Viral Hepatitis-Induced Liver Cirrhosis: A Preliminary Study
Review

Application of Adult and Pluripotent Stem Cells in Interstitial Cystitis/Bladder Pain Syndrome Therapy: Methods and Perspectives

1
Department of Stem Cell & Regenerative Biotechnology and Incurable Disease Animal Model and Stem Cell Institute (IDASI), Konkuk University, 120 Neungdong-ro, Gwangjin-gu, Seoul 05029, Korea
2
Department of Urology, Konkuk University Medical Center, Konkuk University School of Medicine, Seoul 05029, Korea
*
Authors to whom correspondence should be addressed.
Equally contribute.
J. Clin. Med. 2020, 9(3), 766; https://doi.org/10.3390/jcm9030766
Received: 18 February 2020 / Revised: 4 March 2020 / Accepted: 9 March 2020 / Published: 12 March 2020
(This article belongs to the Section Nephrology & Urology)
Interstitial cystitis/bladder pain syndrome (IC/BPS) is a multifactorial, chronic disease without definite etiology characterized by bladder-related pelvic pain. IC/BPS is associated with pain that negatively affects the quality of life. There are various therapeutic approaches against IC/BPS. However, no efficient therapeutic agent against IC/BPS has been discovered yet. Urothelium dysfunction is one of the key factors of IC/BPS-related pathogenicity. Stem cells, including adult stem cells (ASCs) and pluripotent stem cells (PSCs), such as embryonic stem cells (ESCs) and induced PSCs (iPSCs), possess the abilities of self-renewal, proliferation, and differentiation into various cell types, including urothelial and other bladder cells. Therefore, stem cells are considered robust candidates for bladder regeneration. This review provides a brief overview of the etiology, pathophysiology, diagnosis, and treatment of IC/BPS as well as a summary of ASCs and PSCs. The potential of ASCs and PSCs in bladder regeneration via differentiation into bladder cells or direct transplantation into the bladder and the possible applications in IC/BPS therapy are described in detail. A better understanding of current studies on stem cells and bladder regeneration will allow further improvement in the approaches of stem cell applications for highly efficient IC/BPS therapy. View Full-Text
Keywords: IC/BPS; PSCs; ASCs; therapy; regeneration; urothelium; differentiation; transplantation; bladder IC/BPS; PSCs; ASCs; therapy; regeneration; urothelium; differentiation; transplantation; bladder
Show Figures

Figure 1

MDPI and ACS Style

Abdal Dayem, A.; Kim, K.; Lee, S.B.; Kim, A.; Cho, S.-G. Application of Adult and Pluripotent Stem Cells in Interstitial Cystitis/Bladder Pain Syndrome Therapy: Methods and Perspectives. J. Clin. Med. 2020, 9, 766. https://doi.org/10.3390/jcm9030766

AMA Style

Abdal Dayem A, Kim K, Lee SB, Kim A, Cho S-G. Application of Adult and Pluripotent Stem Cells in Interstitial Cystitis/Bladder Pain Syndrome Therapy: Methods and Perspectives. Journal of Clinical Medicine. 2020; 9(3):766. https://doi.org/10.3390/jcm9030766

Chicago/Turabian Style

Abdal Dayem, Ahmed, Kyeongseok Kim, Soo B. Lee, Aram Kim, and Ssang-Goo Cho. 2020. "Application of Adult and Pluripotent Stem Cells in Interstitial Cystitis/Bladder Pain Syndrome Therapy: Methods and Perspectives" Journal of Clinical Medicine 9, no. 3: 766. https://doi.org/10.3390/jcm9030766

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop